AM‐induced microbiome alterations have been linked to dysregulation of metabolism, for example inducing low‐grade inflammation, decreasing insulin sensitivity and altering short‐chain fatty acid (SCFA) and bile acid metabolism,10 which are also present in obesity. The gene discussed is INS; the disease is obesity disorder.